You are here
- Home
- Therapy Areas
- Neuroscience
A Phase I, Single Centre, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Assess the Safety, Tolerability and Pharmacokinetics of Oral AZD2423 Solution After Administration of Multiple Ascending Doses for 12 Days in Young and Elderly Healthy Japanese Volunteers
- Disease
- analgaesia
- Drug Name
- AZD2423
- Generic Name
- AZD2423
- Sponsor
- AstraZeneca
- Drug Status
- In Development
- Phase
- I
- Start Date
- Nov 24, 2010
- Study Name
- D2600C00004
- Study Id
- D2600C00004
- ClinicalTrials.gov ID
- NCT01233830
- Recruiting Status
- Open
- Protocol Status
- Not Available
- Report Status
- Not Available
